159 related articles for article (PubMed ID: 26407988)
1. Predictive Genetic Testing and Alternatives to Face to Face Results Disclosure: A Retrospective Review of Patients Preference for Alternative Modes of BRCA 1 and 2 Results Disclosure in the Republic of Ireland.
O'Shea R; Meany M; Carroll C; Cody N; Healy D; Green A; Lynch SA
J Genet Couns; 2016 Jun; 25(3):422-31. PubMed ID: 26407988
[TBL] [Abstract][Full Text] [Related]
2. More breast cancer patients prefer BRCA-mutation testing without prior face-to-face genetic counseling.
Sie AS; van Zelst-Stams WA; Spruijt L; Mensenkamp AR; Ligtenberg MJ; Brunner HG; Prins JB; Hoogerbrugge N
Fam Cancer; 2014 Jun; 13(2):143-51. PubMed ID: 24068317
[TBL] [Abstract][Full Text] [Related]
3. High Satisfaction and Low Distress in Breast Cancer Patients One Year after BRCA-Mutation Testing without Prior Face-to-Face Genetic Counseling.
Sie AS; Spruijt L; van Zelst-Stams WA; Mensenkamp AR; Ligtenberg MJ; Brunner HG; Prins JB; Hoogerbrugge N
J Genet Couns; 2016 Jun; 25(3):504-14. PubMed ID: 26531312
[TBL] [Abstract][Full Text] [Related]
4. The introduction of a choice to learn pre-symptomatic DNA test results for BRCA or Lynch syndrome either face-to-face or by letter.
Voorwinden JS; Jaspers JP; ter Beest JG; Kievit Y; Sijmons RH; Oosterwijk JC
Clin Genet; 2012 May; 81(5):421-9. PubMed ID: 22091929
[TBL] [Abstract][Full Text] [Related]
5. Initial experience with surgical treatment planning in the newly diagnosed breast cancer patient at high risk for BRCA-1 or BRCA-2 mutation.
Stolier AJ; Fuhrman GM; Mauterer L; Bolton JS; Superneau DW
Breast J; 2004; 10(6):475-80. PubMed ID: 15569201
[TBL] [Abstract][Full Text] [Related]
6. Telephoned BRCA1/2 genetic test results: prevalence, practice, and patient satisfaction.
Baumanis L; Evans JP; Callanan N; Susswein LR
J Genet Couns; 2009 Oct; 18(5):447-63. PubMed ID: 19462222
[TBL] [Abstract][Full Text] [Related]
7. Preoperative genetic testing affects surgical decision making in breast cancer patients.
Lokich E; Stuckey A; Raker C; Wilbur JS; Laprise J; Gass J
Gynecol Oncol; 2014 Aug; 134(2):326-30. PubMed ID: 24910453
[TBL] [Abstract][Full Text] [Related]
8. Patient responses to the disclosure of BRCA mutation tests in hereditary breast-ovarian cancer families.
Lynch HT; Snyder C; Lynch JF; Karatoprakli P; Trowonou A; Metcalfe K; Narod SA; Gong G
Cancer Genet Cytogenet; 2006 Mar; 165(2):91-7. PubMed ID: 16527602
[TBL] [Abstract][Full Text] [Related]
9. Retrospective comparison of patient outcomes after in-person and telephone results disclosure counseling for BRCA1/2 genetic testing.
Doughty Rice C; Ruschman JG; Martin LJ; Manders JB; Miller E
Fam Cancer; 2010 Jun; 9(2):203-12. PubMed ID: 20473602
[TBL] [Abstract][Full Text] [Related]
10. How often do BRCA mutation carriers tell their young children of the family's risk for cancer? A study of parental disclosure of BRCA mutations to minors and young adults.
Bradbury AR; Dignam JJ; Ibe CN; Auh SL; Hlubocky FJ; Cummings SA; White M; Olopade OI; Daugherty CK
J Clin Oncol; 2007 Aug; 25(24):3705-11. PubMed ID: 17704419
[TBL] [Abstract][Full Text] [Related]
11. Experiences of Women Who Underwent Predictive BRCA 1/2 Mutation Testing Before the Age of 30.
Brunstrom K; Murray A; McAllister M
J Genet Couns; 2016 Feb; 25(1):90-100. PubMed ID: 25983051
[TBL] [Abstract][Full Text] [Related]
12. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement.
Moyer VA;
Ann Intern Med; 2014 Feb; 160(4):271-81. PubMed ID: 24366376
[TBL] [Abstract][Full Text] [Related]
13. Genetic uptake in BRCA-mutation families is related to emotional and behavioral communication characteristics of index patients.
Landsbergen K; Verhaak C; Kraaimaat F; Hoogerbrugge N
Fam Cancer; 2005; 4(2):115-9. PubMed ID: 15951961
[TBL] [Abstract][Full Text] [Related]
14. Recruitment, genetic counseling, and BRCA testing for underserved women at a public hospital.
Lee R; Beattie M; Crawford B; Mak J; Stewart N; Komaromy M; Esserman L; Shaw L; McLennan J; Strachowski L; Luce J; Ziegler J
Genet Test; 2005; 9(4):306-12. PubMed ID: 16379544
[TBL] [Abstract][Full Text] [Related]
15. Pretest genetic counseling informs patients with BRCA mutation.
Printz C
Cancer; 2012 Dec; 118(24):6017. PubMed ID: 23208671
[No Abstract] [Full Text] [Related]
16. Orthodox Jewish Thought Leaders' Insights Regarding BRCA Mutations: A Descriptive Study.
Bressler T; Popp B
J Oncol Pract; 2017 Apr; 13(4):e303-e309. PubMed ID: 27875073
[TBL] [Abstract][Full Text] [Related]
17. Implementation and outcomes of telephone disclosure of clinical BRCA1/2 test results.
Patrick-Miller L; Egleston BL; Daly M; Stevens E; Fetzer D; Forman A; Bealin L; Rybak C; Peterson C; Corbman M; Bradbury AR
Patient Educ Couns; 2013 Dec; 93(3):413-9. PubMed ID: 24075727
[TBL] [Abstract][Full Text] [Related]
18. Revisiting breast cancer patients who previously tested negative for BRCA mutations using a 12-gene panel.
Moran O; Nikitina D; Royer R; Poll A; Metcalfe K; Narod SA; Akbari MR; Kotsopoulos J
Breast Cancer Res Treat; 2017 Jan; 161(1):135-142. PubMed ID: 27798748
[TBL] [Abstract][Full Text] [Related]
19. "Maybe they have found something new" participants' views on returning cohort psychosocial survey results.
Bureau E; Pellegrini I; Noguès C; Lasset C; Julian-Reynier C
Health Expect; 2015 Dec; 18(6):2425-36. PubMed ID: 24889689
[TBL] [Abstract][Full Text] [Related]
20. Patient satisfaction and cancer-related distress among unselected Jewish women undergoing genetic testing for BRCA1 and BRCA2.
Metcalfe KA; Poll A; Llacuachaqui M; Nanda S; Tulman A; Mian N; Sun P; Narod SA
Clin Genet; 2010 Nov; 78(5):411-7. PubMed ID: 20653694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
